trial · primary record
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
Anatomic Stage IV Breast Cancer AJCC v8
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Incidence of adverse events (AEs) |
| Registry ID | NCT07112053 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:02.172Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07112053
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.